Francesca Lombardi

14PUBLICATIONS
22CO-AUTHORS
PharmacogenomicsGene and molecular therapyPeriodonticsTraditional, complementary and integrative medicine not elsewhere classifiedBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 15, 2026
'Leaving no stones unturned': up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort.

|Feb 05, 2025
Impact of HBV serological status on HIV virological efficacy of two-drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with HIV switching to lamivudine/dolutegravir.

Pierluigi Francesco Salvo, Arturo Ciccullo, Elena Visconti

|Jan 28, 2025
Levilactobacillus brevis CD2 as a multifaceted probiotic to preserve oral health: results of a double-blind, randomized, placebo-controlled trial in healthy adults.

Serena Altamura, Francesca Lombardi, Francesca Rosaria Augello

|Jan 08, 2025
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational Study.

V Iannone, F Lombardi, A Ciccullo

|Oct 29, 2024
Cardiovascular Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Virologically Suppressed PLWHIV: A Comparative Analysis of CVD Scores.

Arturo Ciccullo, Valentina Iannone, Damiano Farinacci

|Aug 03, 2023
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study.

Francesca Lombardi, Alessia Sanfilippo, Massimiliano Fabbiani

Pageof 3

Frequent Collaborators

5 joint publications

Arturo Ciccullo

4 joint publications

Massimiliano Fabbiani

3 joint publications

Gianmaria Baldin

2 joint publications

Alberto Borghetti